No profile data available.
Caris Life Sciences, Inc. (CAI) is a healthcare company in the DNA testing equipment industry, based in Irving, United States, with about 1,846 full-time employees.
It reported revenue of $812.03 million for fiscal year 2025, up 97.0% from fiscal year 2024, and net income of -$537.96 million. In Q1 2026 (the quarter ended March 31, 2026) revenue was $216.17 million, up 78.8% from a year before. Its market capitalization was $8.39 billion as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
, an artificial intelligence TechBio company, provides molecular profiling services in the United States and internationally. It develops and commercializes solutions to transform healthcare using molecular information, and artificial intelligence/machine learning algorithms.
Caris Life Sciences reported $812.03 million in revenue for fiscal year 2025, up 97.0% from $412.26 million in fiscal year 2024. In Q1 2026 revenue was $216.17 million.
$8.39 billion as of October 9, 2026.
Listed companies of a similar size in the same industry (DNA testing equipment) include Guardant Health, Inc. (GH), Tempus AI, Inc. (TEM), Qiagen N.v. (QGEN), Grail, Inc. (GRAL).